Dongliang Yang to China
This is a "connection" page, showing publications Dongliang Yang has written about China.
Connection Strength
0.096
-
Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. J Med Virol. 2020 05; 92(5):491-494.
Score: 0.031
-
ANDC: an early warning score to predict mortality risk for patients with Coronavirus Disease 2019. J Transl Med. 2020 08 31; 18(1):328.
Score: 0.008
-
Co-infection of SARS-CoV-2 and Influenza virus in Early Stage of the COVID-19 Epidemic in Wuhan, China. J Infect. 2020 08; 81(2):e128-e129.
Score: 0.008
-
Psychological impact of 2019 novel coronavirus (2019-nCoV) outbreak in health workers in China. Epidemiol Infect. 2020 05 20; 148:e96.
Score: 0.008
-
Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine. 2020 May; 55:102763.
Score: 0.008
-
Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China. BMC Gastroenterol. 2019 May 02; 19(1):65.
Score: 0.007
-
Incidence and Etiology of Drug-Induced Liver Injury in Mainland China. Gastroenterology. 2019 06; 156(8):2230-2241.e11.
Score: 0.007
-
Factors influencing patient delay in individuals with haemorrhoids: A study based on theory of planned behavior and common sense model. J Adv Nurs. 2019 May; 75(5):1018-1028.
Score: 0.007
-
Chinese woodchucks with different susceptibility to WHV infection differ in their genetic background exemplified by cytochrome B and MHC-DRB molecules. Virol J. 2018 06 18; 15(1):101.
Score: 0.007
-
CSH guidelines for the diagnosis and treatment of drug-induced liver injury. Hepatol Int. 2017 May; 11(3):221-241.
Score: 0.006